Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bipolar Disorder, Mixed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00606281
What this trial is testing

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 258
Post-approval studies (Phase 4)Study completedNCT00397020
What this trial is testing

Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapine for Adults With Acute Mania or Mixed Episodes

Who this might be right for
Bipolar Disorder
University of California, San Diego 30
Large-scale testing (Phase 3)Study completedNCT03573297
What this trial is testing

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Who this might be right for
Bipolar I DisorderManiaDepression
AbbVie 901
Large-scale testing (Phase 3)Study completedNCT00110461
What this trial is testing

Aripiprazole in Children and Adolescents With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 296
Testing effectiveness (Phase 2)Study completedNCT00206778
What this trial is testing

Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania

Who this might be right for
Mixed Mania Bipolar Disorder
Beth Israel Medical Center 36
Post-approval studies (Phase 4)Study completedNCT00261443
What this trial is testing

Aripiprazole (Abilify) in Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,270
Post-approval studies (Phase 4)Ended earlyNCT02623504
What this trial is testing

DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder

Who this might be right for
Bipolar Disorder
Validus Pharmaceuticals 17
Post-approval studies (Phase 4)Study completedNCT00034580
What this trial is testing

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Eli Lilly and Company 326
Testing effectiveness (Phase 2)Ended earlyNCT06423794
What this trial is testing

BHV-7000 Open-Label Extension Bipolar Mania Study

Who this might be right for
Bipolar Disorder
Biohaven Therapeutics Ltd. 94
Post-approval studies (Phase 4)UnknownNCT01893229
What this trial is testing

Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania

Who this might be right for
Bipolar Disorder
Guiyun Xu 120
Post-approval studies (Phase 4)Study completedNCT00643123
What this trial is testing

Allopurinol Add-on Treatment for Refractory Mania

Who this might be right for
Bipolar DisorderMixed ManiaTreatment-Resistant Mania
Cedars-Sinai Medical Center 40
Large-scale testing (Phase 3)Study completedNCT00035802
What this trial is testing

Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar DisorderAffective Disorders, PsychoticMood Disorders+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 13
Large-scale testing (Phase 3)Study completedNCT00102518
What this trial is testing

Aripiprazole Open-Label, Safety and Tolerability Study

Who this might be right for
SchizophreniaBipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 325
Large-scale testing (Phase 3)Study completedNCT04285515
What this trial is testing

Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder

Who this might be right for
Bipolar DepressionMajor Depressive Disorder
Intra-Cellular Therapies, Inc. 488
Large-scale testing (Phase 3)Study completedNCT00129220
What this trial is testing

Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Eli Lilly and Company 224
Not applicableStudy completedNCT01503489
What this trial is testing

Risk Factors for AD-Associated Switch to Mania

Who this might be right for
Bipolar Disorder
Hospital Clinic of Barcelona 221
Large-scale testing (Phase 3)Study completedNCT00606320
What this trial is testing

A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 59
Large-scale testing (Phase 3)Study completedNCT00240721
What this trial is testing

The Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder

Who this might be right for
Bipolar DisordersMood DisordersAffective Disorders, Psychotic
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 363
Large-scale testing (Phase 3)Study completedNCT00309686
What this trial is testing

Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder

Who this might be right for
Affective Psychosis, BipolarBipolar DisorderMania
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 300
Large-scale testing (Phase 3)Study completedNCT01349907
What this trial is testing

Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)

Who this might be right for
Bipolar Disorder
Organon and Co 322
Next Page